Home / Cancer and immune system / Abiraterone
ATC L02BX03 · Endocrine Therapy
Abiraterone shortage
As of 31 Oct 2026, Abiraterone has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 5 products.
Countries4/5
Products5packs or presentations
Short since20 Mar 202519 months ago
Earliest return6 Nov 2026company estimate
No return date1products
Main reasonIncreased demand
Timeline
GermanyItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Abirateron HEXAL 1000 mg Filmtabletten | H e x a l Aktiengesellschaft | 21 Jan 2026 | 6 Nov 2026 | Increased demand Erhöhte Nachfrage |
| DE | Abirateron HEXAL 1000 mg Filmtabletten | H e x a l Aktiengesellschaft | 21 Jan 2026 | 6 Nov 2026 | Increased demand Erhöhte Nachfrage |
| IT | ABIRATERONE SUN | SUN PHARMA FRANCE | 20 Mar 2025 | not given | Increased demand Elevata richiesta |
| ES | ABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | Mylan Ireland Limited | 14 Oct 2026 | 29 Nov 2026 | Not stated |
| BE | Abiraterone Mylan 1 000 mg film-coat. tabl. 30 (30 x 1) UD | Mylan Pharmaceuticals | 3 Sep 2026 | 23 Dec 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.